Correlation Between Bank of America and Iterum Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bank of America and Iterum Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and Iterum Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank of America and Iterum Therapeutics PLC, you can compare the effects of market volatilities on Bank of America and Iterum Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of Iterum Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and Iterum Therapeutics.
Diversification Opportunities for Bank of America and Iterum Therapeutics
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Bank and Iterum is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and Iterum Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iterum Therapeutics PLC and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with Iterum Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iterum Therapeutics PLC has no effect on the direction of Bank of America i.e., Bank of America and Iterum Therapeutics go up and down completely randomly.
Pair Corralation between Bank of America and Iterum Therapeutics
Considering the 90-day investment horizon Bank of America is expected to generate 4.37 times less return on investment than Iterum Therapeutics. But when comparing it to its historical volatility, Bank of America is 2.5 times less risky than Iterum Therapeutics. It trades about 0.29 of its potential returns per unit of risk. Iterum Therapeutics PLC is currently generating about 0.5 of returns per unit of risk over similar time horizon. If you would invest 121.00 in Iterum Therapeutics PLC on August 31, 2024 and sell it today you would earn a total of 82.00 from holding Iterum Therapeutics PLC or generate 67.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bank of America vs. Iterum Therapeutics PLC
Performance |
| Timeline |
| Bank of America |
| Iterum Therapeutics PLC |
Bank of America and Iterum Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bank of America and Iterum Therapeutics
The main advantage of trading using opposite Bank of America and Iterum Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, Iterum Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iterum Therapeutics will offset losses from the drop in Iterum Therapeutics' long position.| Bank of America vs. RLJ Lodging Trust | Bank of America vs. Aquagold International | Bank of America vs. Stepstone Group | Bank of America vs. Morningstar Unconstrained Allocation |
| Iterum Therapeutics vs. Adial Pharmaceuticals | Iterum Therapeutics vs. Tonix Pharmaceuticals Holding | Iterum Therapeutics vs. Fortress Biotech | Iterum Therapeutics vs. Eyenovia |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Transaction History View history of all your transactions and understand their impact on performance |